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Definitions and terminology
The word eczema derives from the Greek word for 
‘boiling over’. Eczema periodically flares up (or boils 
over). The term dermatitis refers to inflammation of 
the skin, analogous to appendicitis (inflammation of 
the appendix), hepatitis (inflammation of the liver), etc. Currently, 
the terms dermatitis and eczema are generally regarded as synonyms. 
Internationally, however, there is no agreement on the use of these 
terms. The word eczema tends to be a layman’s term, while dermatitis 
is more often used in a scientific context. 
Eczema/dermatitis is not a diagnosis. The most common forms of 
eczema/dermatitis are atopic, seborrhoeic, primary irritant, allergic 
contact, photoallergic, phototoxic, nummular, asteatotic, stasis and 
dyshydrotic. 
Atopy may be defined as a clinical hypersensitivity state subject 
to hereditary influences, including hay fever, asthma and eczema, 
developing against a complex genetic background – the so-called 
atopic diathesis. In the 1980s, Hanifin and Rajka proposed a list of 
criteria, leading to agreement regarding the clinical concept of atopic 
dermatitis (AD). In 1994, a UK Working Party refined these criteria 
in a concise and validated set of survey-based diagnostic criteria 
useful for the purposes of epidemiological studies, as set out below. 
Atopic in the term atopic eczema is simply an indicator of the 
frequent association of this condition with atopy and the need to 
separate this clinical phenotype from other forms of eczema. The 
terms atopic eczema and AD are synonymous.
According to the position paper of the Nomenclature Review 
Committee of the World Allergy Association,[1] the term atopic 
eczema/dermatitis syndrome (AEDS) should be used as the umbrella 
term covering the different subtypes of AD. The new nomenclature 
(AEDS) underlines that AD is not one single disease entity, but 
rather an aggregation of several diseases that have certain clinical 
characteristics in common.
Intrinsic AD (non-allergic AEDS (NAAEDS) or atopiform 
dermatitis) fulfils the most commonly used diagnostic criteria 
for AD. Patients with intrinsic AD have no associated respiratory 
diseases, such as bronchial asthma or allergic rhinitis, present with 
normal total serum IgE levels, have no specific IgE, and manifest 
negative skin-prick tests to aeroallergens or foods. In one study, 
intrinsic AD was more common in females and disease onset was 
later. This group comprised at least 20% (up to 60%) of cases.[2]
Extrinsic AD (allergic AEDS (AAEDS)) is commonly associated 
with respiratory allergies such as rhinitis and asthma, high levels of 
serum IgE, specific IgE, and positive skin-prick tests to aeroallergens 
or foods. Immunological differences between NAAEDS and AAEDS 
can be found in the cell and cytokine patterns in peripheral blood and 
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affected skin, and also by phenotyping characterisation of epidermal 
dendritic cells. This group comprises 40 - 80% of patients.[2] 
The classification into AAEDS and NAAEDS at each stage of life, 
i.e. infancy, childhood, adolescence and adulthood, is essential for the 
allergological management of patients regarding allergen avoidance, 
secondary allergy prevention, and immunotherapy. The risk of an 
‘atopy march’ is significantly lower in children with NAAEDS than 
in those with AAEDS.[3] This subdivision is controversial. Cases may 
transform from one type to another and this division may not be 
applicable to adults. Until the exact genetic and causative agents are 
known, one should consider the clinical disease as one condition.
Acute eczema/dermatitis is characterised by oedema, erythema, 
vesiculation, exudation and crusting. Chronic eczema/dermatitis 
is characterised by lichenification, which refers to thickening of 
the skin with exaggeration of normal markings. Flat-topped, shiny, 
quadrilateral coalescing papules are enclosed. Subacute eczema/
dermatitis shows features that overlap with those of acute and 
chronic eczema/dermatitis, i.e. commonly slightly elevated, and red, 
brownish or purplish in colour, with variable scaling. Generally, the 
subacute presentation of eczema/dermatitis is more common.
The morphology, distribution and evolution of eczema/dermatitis 
in atopic eczema/dermatitis are highly characteristic and age 
dependent: 
• Infant phase (birth - 2 years): red scaly lesions typically develop 
on the cheeks, usually sparing the peri-oral and perinasal areas. 
The chin is typically involved and cheilitis is common. A small but 
significant number of infants develop a generalised eruption, and 
involvement of the scalp is not uncommon. The nappy area is often 
spared, but sometimes the cubital/popliteal fossae or other parts of 
the limbs are involved. 
• Childhood phase (2 - 12 years): eczema/dermatitis involves the 
flexural areas (i.e. the cubital and popliteal fossae) and the neck, 
wrist and ankles. 
• Adolescent and adult phases (12 years - adulthood): involvement 
is similar to the childhood phase. Additionally, hand, peri-ocular 
and anogenital eczema/dermatitis are common. Sometimes lesions 
occur on extensor surfaces, and follicular accentuation may be 
prominent.
Morphologically, lesions may be classified as acute, subacute or 
chronic. Atopic eczema is a difficult disease to define, as the clinical 
features are highly variable with regard to morphology, body site and 
time. Diagnosis is therefore essentially clinical.[4]
Aetiopathogenesis 
The aetiopathogenesis of AD is probably multifactorial. Current 
thinking favours a skin barrier defect as the most significant 
predisposing factor, where mutations in the filaggrin gene feature 
strongly.[5,6] Most studies on the causes of AD have been performed 
in children. There is little to suggest that adult AD should have a 
different aetiopathogenesis, except for some clinical features that 
differ, such as the predominant involvement of the hands and the 
head and neck.[7]
Genetics
Population-based family studies in Europe suggest that in atopic 
families up to 50% of offspring will have AD.[8] Twin studies showing 
a concordance rate of 0.75 for monozygotic twins and 0.20 for 
dizygotic twins support a genetic basis for AD.[8-10] Candidate genes 
are further evidence for a genetic predisposition.[8,10]
Allergic sensitisation
The predisposition for IgE hyper-responsiveness to allergens defines 
the term atopy.[1] A systematic review of the published evidence 
for allergic sensitisation and dermatitis in 12 population studies 
worldwide has shown that IgE hyper-responsiveness does not 
necessarily equate to AD, even though it may be associated with 
the disease phenotype, especially in severe disease.[2,11] Geographical 
location was associated with the risk of being atopic among those 
with AD compared with normal healthy controls.
In five studies that included adolescents and adults, the findings 
were essentially similar. In a cross-sectional household survey from 
Ethiopia, which included adults and children, 15% of those with AD 
and 8% of those without AD were atopic on skin-prick testing.[12] 
This lack of association between AD and allergen sensitisation in that 
setting was confirmed in a cross-sectional survey and nested case-
controlled study in children.
Environment
An increasing prevalence of AD over the past 50 years is not consistent 
with genetic drift alone, but supports a strong environmental 
influence as evidenced by population migration studies.[13] These 
environmental influences, which affect initial disease expression or 
aggravation of established disease, are summarised below. However, 
population studies from Africa seldom confirm a role for the 
environmental factors.[12] Interestingly, many are surrogate markers of 
urbanisation[14] and increased socioeconomic status,[14] which appear 
to be the only fairly consistent associations across all population 
groups.
The aetiopathogenesis of AD is best explained by the concept 
of a damaged barrier function, whether intrinsically normal or 
dysfunctional, that induces a state of epidermal repair, coupled with 
aberrant responses to epidermal insults of the affected skin.[8,10,14,15] In 
Africa, this hypothesis has not yet been validated. A novel filaggrin 
gene defect has been documented in a single Ethiopian case of AD.[16] 
What evolutionary advantage the skin barrier defect conveyed to the 
populations now exposed to environmental influences precipitating 
atopic disease, is unknown. 
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Environmental inuences
The following factors have been shown to increase the risk for/
prevalence of AD:
• rural compared with urban living (hygiene hypothesis)[13,14,17,18]
• maternal AD history (parent-of-origin effect)[10,18,19]
• higher socioeconomic status[12,14,20]
• higher educational level of parents[21]
• smaller family size (hygiene hypothesis)[17,22]
• improved basic hygiene (hygiene hypothesis)[17]
• antibiotic use early in life (hygiene hypothesis)[17,21]
• caesarean section delivery[23]
• increased maternal age[19]
• environmental tobacco smoke (major risk)[13]
• contact dermatitis[24,25]
• cooler climates[13]
• clothing with rough fibres[26]
• environmental pollution[13,17]
• psychosocial stress.[21,23]
The following factors have been shown to decrease the risk for/
prevalence of AD:
• day-care attendance[17]
• animal exposure early in life (hygiene hypothesis)[17,21,23]
• endotoxin exposure in early infancy (hygiene hypothesis)[17]
• infections early in life (hygiene hypothesis)[17]
• breastfeeding[19,27,28]
• fully hydrolysed formula feeds[21,27,28]
• vaccination (hygiene hypothesis).[17,19]
The following factors have not been inconclusively shown to affect 
the risk for/prevalence of AD:
• parasite infestation[15,17]
• maternal diet[18,19,23,26,28]
• maternal probiotic use[19,23,26]
• diet restriction[21,27]
• elemental diet[21,27]
• organic food[21]
• solid food introduction[21,27]
• diet supplementation with antioxidants, essential fatty acids, 
probiotics[18,19,21,26-28]
• staphylococcal control[18,21,26]
• hard water – no effect if calcium carbonate is removed[20]
• reduced house dust mite exposure[18,21,26] 
• clothes softeners.[26]
Food allergy
The inter-relationship between AD and food allergy is complex. 
Many patients and/or their carers believe that it is caused by 
something in their diet; however, it is rarely diet alone that triggers 
AD. Tests for food allergy should not routinely be done in all cases 
of AD. Concomitant or causative food allergy should be considered 
in patients with a convincing history of food allergy and those with 
moderate to severe eczema that does not respond to appropriate and 
adequate topical treatment.
Sensitisation to foods (raised ImmunoCAP values or positive 
skin-prick tests) is common in AD, but not synonymous with 
clinically relevant food allergy. About 60% of patients with AD are 
sensitised to food allergens[29] – a much higher percentage than the 
overall prevalence of food sensitisation in the general population. 
In 2011, infants attending a tertiary dermatology clinic for AD 
were shown to have high sensitisation rates (66% to at least one 
food), most commonly to egg (52%), peanuts (39%) and cow’s milk 
(25%).[30] 
Approximately 30 - 40% of children with AD have a co-existing 
food allergy,[29] but this is much less common in adults. 
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Abstract. South African Journal of Child Health 2011;5(3):99.
We know from numerous efficacy trials over several 
decades that bacillus Calmette-Guérin (BCG) has 
60 - 80% protective efficacy against severe forms of 
tuberculosis (TB) in children, particularly meningitis, 
but that its efficacy against pulmonary disease varies 
geographically. The latter is probably because BCG does not seem 
to protect against disease when given to those already infected or 
sensitised to environmental mycobacteria. The purpose of this recent 
study was to determine whether BCG vaccination protects against 
Mycobacterium tuberculosis infection, as assessed by interferon γ release 
assays (IGRA) in children.
Roy et al. conducted a systematic review and meta-analysis 
using searches of electronic databases from 1950 to November 
2013. Inclusion criteria were vaccinated and unvaccinated 
children under 16 years of age with known recent exposure to 
patients with pulmonary TB. Children were screened for M. 
tuberculosis infection with IGRA. Primary analysis included 
14 studies and 3  855 participants. The estimated overall risk 
ratio was 0.81, indicating a protective efficacy of 19% against 
infection among vaccinated children after exposure compared 
with unvaccinated children. Among those infected, protection 
against progression to disease was 58%. This study suggests that 
BCG protects against M. tuberculosis infection and progression 
from infection to disease.
Roy A, Eisenhut M, Harris RJ, et al. Br Med J 2014;349:g4643. [http://dx.doi.org/10.1136/bmj.4643] 
ABSTRACT
Is BCG vaccination effective against Mycobacterium tuberculosis in children?
The full version of the article is available online. Use the QR code above to access.
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